These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30976913)

  • 1. Impact of cytomegalovirus load on host response to sepsis.
    Marandu T; Dombek M; Cook CH
    Med Microbiol Immunol; 2019 Aug; 208(3-4):295-303. PubMed ID: 30976913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broncholaveolar lavage to detect cytomegalovirus infection, latency, and reactivation in immune competent hosts.
    Mansfield S; Dwivedi V; Byrd S; Trgovcich J; Griessl M; Gutknecht M; Cook CH
    J Med Virol; 2016 Aug; 88(8):1408-16. PubMed ID: 26762116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepsis and cytomegalovirus: foes or conspirators?
    Mansfield S; Grießl M; Gutknecht M; Cook CH
    Med Microbiol Immunol; 2015 Jun; 204(3):431-7. PubMed ID: 25788396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus reactivation in "immunocompetent" patients: a call for scientific prophylaxis.
    Cook CH
    J Infect Dis; 2007 Nov; 196(9):1273-5. PubMed ID: 17922387
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytomegalovirus immunoglobulin G titers do not predict reactivation risk in immunocompetent hosts.
    Mansfield SA; Dwivedi V; Elgharably H; Griessl M; Zimmerman PD; Limaye AP; Cook CH
    J Med Virol; 2019 May; 91(5):836-844. PubMed ID: 30609051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of cytomegalovirus reactivation on clinical outcomes in immunocompetent critically ill patients: protocol for a systematic review and meta-analysis.
    Lachance P; Chen J; Featherstone R; Sligl W
    Syst Rev; 2016 Jul; 5(1):127. PubMed ID: 27465807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivation of Cytomegalovirus Increases Nitric Oxide and IL-10 Levels in Sepsis and is Associated with Changes in Renal Parameters and Worse Clinical Outcome.
    Silva TF; Concato VM; Tomiotto-Pellissier F; Gonçalves MD; Bortoleti BTDS; Tavares ER; Yamauchi LM; Grion CMC; Simão ANC; Miranda-Sapla MM; Costa IN; Pavanelli WR; Conchon-Costa I
    Sci Rep; 2019 Jun; 9(1):9016. PubMed ID: 31227794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Cytomegalovirus Reactivation and Association With Outcomes in Critically Ill Adults With Sepsis: A Pooled Analysis of Prospective Studies.
    Imlay H; Dasgupta S; Boeckh M; Stapleton RD; Rubenfeld GD; Chen Y; Limaye AP
    J Infect Dis; 2021 Jun; 223(12):2108-2112. PubMed ID: 33159200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus reactivation and tumour necrosis factor.
    Döcke WD; Prösch S; Fietze E; Kimel V; Zuckermann H; Klug C; Syrbe U; Krüger DH; von Baehr R; Volk HD
    Lancet; 1994 Jan; 343(8892):268-9. PubMed ID: 7905100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivation of Latent Cytomegalovirus Infection after Major Surgery: Risk Factors and Outcomes.
    Gardiner BJ; Herrick KW; Bailey RC; Chow JK; Snydman DR
    Surg Infect (Larchmt); 2019 Jul; 20(5):416-423. PubMed ID: 30912706
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of cytomegalovirus reactivation on the time course of systemic host response biomarkers in previously immunocompetent critically ill patients with sepsis: a matched cohort study.
    van de Groep K; Nierkens S; Cremer OL; Peelen LM; Klein Klouwenberg PMC; Schultz MJ; Hack CE; van der Poll T; Bonten MJM; Ong DSY;
    Crit Care; 2018 Dec; 22(1):348. PubMed ID: 30563551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus infection in patients with bacterial sepsis.
    Ho M
    Clin Infect Dis; 1998 May; 26(5):1083-4. PubMed ID: 9597230
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of cytomegalovirus reactivation in cancer patients receiving chemotherapy.
    Kuo CP; Wu CL; Ho HT; Chen CG; Liu SI; Lu YT
    Clin Microbiol Infect; 2008 Mar; 14(3):221-7. PubMed ID: 18070129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status.
    Servais S; Dumontier N; Biard L; Schnepf N; Resche-Rigon M; Peffault de Latour R; Scieux C; Robin M; Meunier M; Xhaard A; Sicre de Fontbrune F; Le Goff J; Socié G; Simon F; Mazeron MC
    Clin Microbiol Infect; 2016 Mar; 22(3):289.e1-7. PubMed ID: 26627339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
    Retina; 2000; 20(2):151-5. PubMed ID: 10783947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus load in whole blood is more reliable for predicting and assessing CMV disease than pp65 antigenaemia.
    Hardie DR; Korsman SN; Hsiao NY
    J Virol Methods; 2013 Oct; 193(1):166-8. PubMed ID: 23792685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cytomegalovirus infection inhibits response of chronic hepatitis-C-virus-infected patients to interferon-based therapy.
    Bader el-Din NG; Abd el-Meguid M; Tabll AA; Anany MA; Esmat G; Zayed N; Helmy A; el-Zayady AR; Barakat A; el-Awady MK
    J Gastroenterol Hepatol; 2011 Jan; 26(1):55-62. PubMed ID: 21175794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A constant companion: immune recognition and response to cytomegalovirus with aging and implications for immune fitness.
    Souquette A; Frere J; Smithey M; Sauce D; Thomas PG
    Geroscience; 2017 Jun; 39(3):293-303. PubMed ID: 28647907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons learned from HIV pathogenesis and therapy: implications for better management of cytomegalovirus disease.
    Hardy WD
    AIDS; 1996 Nov; 10 Suppl 1():S31-5. PubMed ID: 8970674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice.
    Cook CH; Zhang Y; Sedmak DD; Martin LC; Jewell S; Ferguson RM
    Crit Care Med; 2006 Mar; 34(3):842-9. PubMed ID: 16521279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.